E

PAVmed Inc. PAVM

$2.05 -$0.05-2.15% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$2.04$2.29
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

PAVM Rating

Reward
Risk

PAVM Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

PAVM Company Overview

PAVmed Inc. is a diversified commercial-stage medical technology company focused on developing, acquiring, and commercializing healthcare products and technologies across multiple clinical areas. The company operates primarily in the medical device and digital health industries, with activities spanning minimally invasive technologies, diagnostics, cancer detection, and healthcare infrastructure solutions. PAVmed’s business model combines internal product development with majority-controlled subsidiaries that pursue targeted commercialization strategies in specialized healthcare markets.

The company’s primary revenue drivers and strategic focus have centered on its ownership interests in Lucid Diagnostics Inc., which develops esophageal precancer detection technologies, and Veris Health Inc., a digital health and remote patient monitoring platform. Historically, PAVmed also developed products in areas such as infusion therapy and gastrointestinal technologies. Founded in 2014 by medical device entrepreneur Lishan Aklog, the company evolved from a single-product development platform into a holding-company-style healthcare technology organization with multiple operating subsidiaries and public market financing relationships.

Data compiled by narrative technology. May contain errors.
Sector

PAVM Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

PAVM Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

PAVM Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

PAVM Price History

Loading...
52-Week Range0% of range
Current
$2.05
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

PAVM Valuation

Market Cap
Market Cap Rank
#14,256
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

PAVM Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

PAVM Corporate Info

Phone Number
917 813 1828
Address
360 Madison Avenue
25th Floor
New York, NY 10017
Country
Year Founded

PAVM Filings

Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

PAVM Headlines

8/15/2026 - Nasdaq News: Markets
8/14/2026 - Seeking Alpha: Transcripts